SCHEMBL13614320

SCHEMBL13614320

CCCc1ccc(-c2ccc(Br)cc2C)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RARB P10826 1/20 0.47
POLB P06746 1/20 0.41
CTDSP1 Q9GZU7 1/20 0.41
FFAR1 O14842 1/20 0.39
NPC1 O15118 3/20 0.38
RAB9A P51151 3/20 0.38
NFKB1 P19838 2/20 0.38
NFKB2 Q00653 2/20 0.38
RELA Q04206 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
GAA P10253 1/20 0.38
CNR1 P21554 1/20 0.38
CNR2 P34972 1/20 0.38
PPARG P37231 2/20 0.37
ALOX5 P09917 1/20 0.37
MAPT P10636 1/20 0.37
GFER P55789 1/20 0.37
MCL1 Q07820 1/20 0.36
MAPK1 P28482 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12002448 0.82 FFAR1 (0.40) RARBFFAR1
SCHEMBL6684291 0.81 RARB (0.48) RARBPOLBCTDSP1NPC1RAB9A
SCHEMBL679627 0.81 ESR2 (0.42) NPC1RAB9ASMN1; SMN2CNR1CNR2
SCHEMBL30414134 0.81 ESR2 (0.42) NPC1RAB9ASMN1; SMN2CNR1CNR2
SCHEMBL15725347 0.81 RARB (0.51) RARBNPC1RAB9ACNR1CNR2
SCHEMBL18323220 0.80 POLB (0.36) RARBPOLBCTDSP1FFAR1NPC1
SCHEMBL12069780 0.80 RARB (0.38) RARBPOLBCTDSP1NPC1RAB9A
SCHEMBL18323226 0.80 POLB (0.36) RARBPOLBCTDSP1FFAR1NPC1
SCHEMBL18527366 0.80 RARB (0.58) RARBNPC1RAB9ANFKB1NFKB2
SCHEMBL18527371 0.80 RARB (0.58) RARBNPC1RAB9ANFKB1NFKB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7618690-B2 Polymerizable liquid crystal compound, liquid crystal composition, optical anisotropic material and optical element ASAHI GLASS COMPANY, LIMITED (JP) 2009-11-17 US disclosed
US-7618690-B2 Polymerizable liquid crystal compound, liquid crystal composition, optical anisotropic material and optical element ASAHI GLASS COMPANY, LIMITED (JP) 2009-11-17 US disclosed
US-20080204650-A1 POLYMERIZABLE LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION, OPTICAL ANISOTROPIC MATERIAL AND OPTICAL ELEMENT ASAHI GLASS COMPANY LIMITED (JP) 2008-08-28 US disclosed
US-20080204650-A1 POLYMERIZABLE LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION, OPTICAL ANISOTROPIC MATERIAL AND OPTICAL ELEMENT ASAHI GLASS COMPANY LIMITED (JP) 2008-08-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080204650-A1 POLYMERIZABLE LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION, OPTICAL ANISOTROPIC MATERIAL AND OPTICAL ELEMENT CCNE2, CCNE1, CCNL2 RARB 2355/4885POLB 2985/4885CTDSP1 1656/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.